Jul. 27, 2022

BMS-986120

oral PAR4 antagonist Ph. II completed in thrombosis (discontinued) HTS, potency, and PK opt. J. Med. Chem. Bristol-Myers Squibb, Princeton, NJ

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in